Immediate versus delayed dental implant placement: an umbrella review protocol Authors: Mateo Ron Canelos, Natalia de Oliveira Miranda, Juan Pablo Simbaña Balseca, César Magalhães Benfatti, Franz Strauss, Edwin Ruales-Carrera, Patrícia Pauletto, Gabriel Leonardo Magrin Published: 2026 ABSTRACT AbstractIntroductionImmediate dental implant placement has been proposed as a strategy to reduce treatment time and improve patient satisfaction. However, systematic reviews addressing immediate versus delayed implant placement have reported inconsistent findings, limiting clinical interpretability. An umbrella review is warranted to synthesise, appraise and contextualise the existing evidence.Methods and analysisThis umbrella review will include systematic reviews with or without meta-analysis comparing immediate implant placement after tooth extraction with delayed placement in healed sites. Comprehensive searches will be conducted in September 2026, in PubMed/Medical Literature Analysis and Retrieval System Online (MEDLINE), Embase, Scopus, Web of Science, LILACS, the Cochrane Database of Systematic Reviews. Methodological quality will be assessed using A Measurement Tool to Assess Systematic Reviews (AMSTAR 2). Overlap of primary studies will be quantified using the corrected covered area. Outcomes of interest include implant survival, success and failure rates, biological and technical complications, patient-reported outcomes and surgical time. A structured narrative synthesis will be performed.Ethics and disseminationThis overview does not require ethics approval, as it uses secondary data from previously published studies. The results will be disseminated through the publication in a high-impact journal.OSF registration number https://doi.org/10.17605/OSF.IO/GZ3DR STRENGTHS AND LIMITATIONS OF THIS STUDY This umbrella review will synthesise evidence from systematic reviews and meta-analyses comparing immediate and delayed dental implant placement. This umbrella review will synthesise evidence from systematic reviews and meta-analyses comparing immediate and delayed dental implant placement. The protocol follows established umbrella review methodology and is reported according to Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). The protocol follows established umbrella review methodology and is reported according to Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). A comprehensive search of electronic databases and grey literature will minimise the risk of missing relevant evidence. A comprehensive search of electronic databases and grey literature will minimise the risk of missing relevant evidence. The broad eligibility criteria may increase clinical heterogeneity across implant locations, rehabilitation protocols and surgical approaches. The broad eligibility criteria may increase clinical heterogeneity across implant locations, rehabilitation protocols and surgical approaches. Conclusions may be limited by the quality of included reviews and overlap of primary studies. Conclusions may be limited by the quality of included reviews and overlap of primary studies. Introduction The timing for dental implant placement corresponds to a way of planning, organising and executing implant dentistry considering the biological factors that play a role in osseointegration at post extraction sites at different time frames. For this purpose, a classification with four categories for implant placement timings after tooth extraction was introduced by Hämmerle et al,1 and later modified by Chen and Buser.2 Immediate or type I implant placement consists of the placement of the implant immediately or less than 10 days after tooth extraction is performed.3 Type II is considered an early implant placement with complete soft tissue healing, which occurs between 4 and 8 weeks after tooth extraction. Type III is also considered an early type of implant placement that occurs between 12 and 16 weeks after tooth extraction and differentiates by displaying a partial bone healing. Finally, type IV or delayed implant placement is characterised by a complete bone tissue healing that occurs only between 4 and 6 months after tooth extraction.4–6 Delayed or type IV timing for implant placement has been considered as a gold standard of care for implant dentistry since it offers more feasibility and predictability than other timings.7 Other biological advantages like complete tissue maturation, better implant stability, less volumetric changes after implantation, optimal three-dimensional implant positioning, adequate keratinised mucosa and ability to meticulously elevate flaps make the delayed approach to be considered as the safest.6 These benefits provide a relatively simplified alternative to execute the surgical procedure while also reducing the risk of complications, particularly for inexperienced clinicians. Nevertheless, prolonged treatment time, as well as the volumetric loss of dimensions of the alveolar bone and the surrounding soft tissues are some of the greatest disadvantages of this treatment modality.8 On the other hand, immediate implant placement (IIP) offers a quicker alternative that maintains the soft tissue architecture, prevents migration of teeth, helps with tissue preservation, patient satisfaction and aesthetic outcomes. Currently, advancements in the concept of immediacy have reshaped the way implant dentistry is performed and publications about this topic have experienced an exponential growth.9 Despite being considered a challenging clinical scenario, IIP is widely used in cases ranging from single tooth replacement in the aesthetic zone until full mouth rehabilitation surgical protocols. In fact, success rates for single immediate implants were reported between 96.7% and 100%.10 Nevertheless, after almost 60 years of IIP history and literature, there is still a considerable number of clinicians who do not consider IIP as a viable nor safe treatment alternative in comparison with late or type IV implant placement. Disadvantages like the unpredictable soft tissue healing, reduced primary stability and challenging execution support this philosophy.4 5 Both immediate and delayed implant placement show survival rates superior to 90% over a 10-year time frame, where systematic reviews have not shown significant differences while comparing survival rates between them, suggesting that IIP is a valuable clinical alternative.11–13 By the other hand, other systematic reviews as well as other primary studies show statistically significant differences in failure rates and inferior survival rates for IIP when compared with delayed implants,7 8 14–17 which is contradictory and supports the philosophy that deems IIP as an unnecessary risk that strengthens immediatism without prioritising the long-term performance of the dental implant therapy.18 This umbrella review will provide a comprehensive appraisal of the existing systematic reviews comparing immediate and delayed dental implant placement. By integrating assessments of methodological quality and overlap, this study aims to clarify inconsistencies in the literature and support evidence-based clinical decision-making in implant dentistry. Objectives Primary To synthesise the evidence comparing survival, success, failure and complications between immediate and delayed implant placement. Secondary To explore methodological and clinical characteristics that may explain differences in reported outcomes among systematic reviews. Methods Protocol and registration This protocol is reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines19 (online supplemental appendix 1). The overview will be reported following the Preferred Reporting Items for Overviews of Reviews statement (PRIOR).20 The study protocol planning started in December 2025, with plans to complete the study by December 2026. Research question The Patient, Population or Porblem, Intervention, Comparison, Outcome, Study Design (PICOS) mnemonic will be used as a guide to delimitate and construct the research question. Figure 1 represents the PICOS structure used in the review question: ‘What is the current body of evidence regarding the comparative clinical performance of immediate and delayed implant placement, and which clinical or methodological characteristics may explain variations in reported outcomes across systematic reviews?’ ‘PICOS’ mnemonic as a guide to identifying the research question. Image generated with canva.com. Eligibility criteria Systematic reviews with or without meta-analysis evaluating the clinical performance of IIP after tooth extraction compared with delayed implant placement in healed sites will be included. Reviews must include human clinical review, the minimum methodological criteria proposed by the Cochrane Handbook for Systematic Reviews of Interventions.21 These include: Having a clearly stated set of objectives with predefined eligibility criteria for studies. Having a clearly stated set of objectives with predefined eligibility criteria for studies. Having conducted a systematic search that attempted to identify all studies that met the stated eligibility criteria. Having conducted a systematic search that attempted to identify all studies that met the stated eligibility criteria. Having employed an explicit, reproducible methodology. Having employed an explicit, reproducible methodology. Having assessed the validity of the findings of the included studies. Having assessed the validity of the findings of the included studies. Having systematically presented and synthesised the characteristics and findings of the included articles. Having systematically presented and synthesised the characteristics and findings of the included articles. No time nor primary study restrictions are going to be considered for the screened systematic reviews. Inclusion criteria To maximise the study’s scope, the umbrella review will include systematic reviews evaluating dental implants placed in all clinical scenarios, irrespective of implant location or rehabilitation protocol. This includes single-tooth replacements, partially edentulous patients, full-arch rehabilitations, implants placed in anterior or posterior regions and implants placed with or without adjunctive grafting procedures or immediate loading protocols. No restrictions regarding implant position, prosthetic design, loading protocol or the use of bone augmentation procedures will be applied. Systematic reviews evaluating multiple implant-placement timings will be eligible provided that outcome data for immediate (Type I) and delayed (Type IV) implant placement can be extracted separately. Exclusion criteria Publication types not consistent with systematic reviews like narrative reviews, scoping reviews, primary studies, letters to the editor, editorials, case reports, book chapters, papers and proceedings or conference papers. Publication types not consistent with systematic reviews like narrative reviews, scoping reviews, primary studies, letters to the editor, editorials, case reports, book chapters, papers and proceedings or conference papers. Systematic reviews without information about success, survival, failure or complication rates. Systematic reviews without information about success, survival, failure or complication rates. Reviews in which immediate and delayed implant-placement outcomes are pooled with early implant placement (Types II and III) and cannot be disaggregated will be excluded, as they do not allow a direct comparison between the interventions of interest. Reviews in which immediate and delayed implant-placement outcomes are pooled with early implant placement (Types II and III) and cannot be disaggregated will be excluded, as they do not allow a direct comparison between the interventions of interest. Outcomes Primary outcome This umbrella review aims to compare clinically relevant outcomes reported in existing systematic reviews of immediate versus delayed dental implant placement. The primary outcome is a comparison of clinical performance of immediate and delayed implant placement. Survival will be defined as the implant remaining in situ and supporting a functional prosthetic restoration. Implant success, defined as the absence of peri-implant pathological changes including infection, inflammation or marginal bone loss beyond accepted thresholds (≤1.5 mm during the first year of function and ≤0.2 mm annually thereafter) will also be assessed. Implant failure, defined as implant loss due to spontaneous exfoliation or surgical removal resulting from mobility, loss of osseointegration or infection. Complication rates, encompassing early and late biological, mechanical, aesthetic, surgical or technical complications reported during the follow-up period. Secondary outcome In addition to synthesising the comparative outcomes between immediate and delayed implant placement, a narrative exploration of clinical and methodological characteristics will be conducted to identify potential factors that may contribute to heterogeneity in survival, success, failure and complication rates across systematic reviews. The broad eligibility criterion was selected to provide a comprehensive synthesis of the available evidence comparing immediate and delayed implant placement across different clinical settings. Clinical characteristics that may contribute to differences in implant survival, success, failure or complication rates will be extracted and considered during the narrative synthesis to identify potential sources of heterogeneity. Information sources and search strategy The preliminary search strategy will be developed with collaboration of an experienced librarian in healthcare topics to guarantee a correct delimitation and structure in all databases. The individual search equations used for each database will be presented through an online supplemental appendix (online supplemental appendix 2) to ensure transparency and predictability. Electronic searches will be conducted in MEDLINE (via PubMed), Embase, Scopus, Web of Science, LILACS (in Spanish: Literatura Latinoamericana y del Caribe en Ciencias de la Salud) and the Cochrane Database. Additionally, a search for grey literature will be conducted on Google Scholar and ProQuest Dissertation and Theses Global. The search strategy will combine controlled vocabulary and free-text terms related to dental implants, immediate placement, delayed placement and systematic reviews. Reference lists of included reviews and experts will be consulted for additional studies. Comprehensive searches will be conducted in September 2026. In addition to database searches, supplementary methods will be employed to identify potentially relevant studies. These methods include backward citation screening of reference lists from eligible studies and forward citation searching using citation-tracking tools to identify subsequent publications citing these studies. Data management Once identified all articles are going to be inserted into the Zotero Reference Manager (V.7.0.3, Corporation for Digital Scholarship, Vienna, VA, USA). Within the reference manager the duplicated articles from different databases are going to be identified and eliminated prior to the beginning of the screening process. Later, another software for reference management (Rayyan Online Software; Qatar Computing Research Institute, Data Analytics, Doha, Qatar) is going to be used to perform the screening process. Selection process Considering the eligibility criteria, the initial phase of the screening process will begin by calibrating three authors (MRC, NdOM and JPSB) to ensure the proper criteria are being applied for both the inclusion and exclusion of the articles. Once proper calibration is confirmed, the three reviewers (MRC, NdOM and JPSB) will independently read the titles and abstracts to select the potentially useful articles and discard the irrelevant ones. The following stage will consist of the full-text assessment of potentially eligible reviews. If disagreements are encountered, first there will be an attempt to resolve them through discussion between the reviewers. If the attempt to resolve the disagreements through discussion between the reviewers is unsuccessful, consultation with a fourth reviewer (CMB) will be performed to yield a definitive assessment of eligibility criteria and final decision about the disagreements. If the selected articles lack certain crucial information, an attempt to retrieve the missing data will be performed by contacting the authors. If not possible, the articles will be discarded. Data collection process Once the selection and reading stages are completed, two independent reviewers (MRC and NdOM) will retrieve the relevant data from the included articles by collecting and exporting it into an electronic previously standardised data extraction sheet (Microsoft Excel software, V.365, Redmond, WA, USA: Microsoft Corporation; 2023). The third reviewer (JPSB) will assess the entirety of the data extraction sheet and verify if the information is complete, accurate and precise. If any disagreement occurs, a new discussion between reviewers will be performed as an attempt to solve it. If missing information is encountered, three attempts of clarification will be carried out with the corresponding author of the included studies. If no response is received within 3 weeks, the information will be registered as missing data. Data items Relevant information about publication data, study characteristics, PICOS delimitation, clinical performance indicators, methodology, conclusions and final considerations will be retrieved. Data items will include: registration, PRISMA adherence, number of primary studies, databases searched, search date/coverage, language/time restrictions, population characteristics, intervention, comparator, inclusion criteria, exclusion criteria, participants (n), follow-up period, primary study design, implant survival rate, implant success rate, implant failure rate, biological complications, prosthetic complications, aesthetic outcomes, patient satisfaction/Patient-Reported Outcome Measures (PROMs), risk of bias tool used, Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessment report, meta-analysis performed, main methodological limitations, publication bias assessed, authors’ conclusions, clinical relevance, research gaps identified. Risk of bias assessment The methodological quality of the included systematic reviews will be assessed using the AMSTAR 2 tool, which is designed to appraise systematic reviews of healthcare interventions. The assessment will be supported by the AMSTAR 2 online checklist to ensure standardised and transparent application of the criteria. The confidence rating of the included systematic reviews will be categorised as high, moderate, low or critically low confidence.22 Assessment of overlap Overlap of primary studies across systematic reviews will be evaluated using a citation matrix and quantified using the corrected covered area (CCA). The degree of overlap will be classified as slight, moderate, high or very high.23 Synthesis methods A narrative synthesis will be the formal method to merge all the relevant data extracted from the selected systematic reviews. Findings will be represented in summary tables, colour charts and figures that combine data for each individual systematic review. To diminish repetitiveness of inclusion of primary studies analysed on the selected systematic reviews, an overlap analysis of possible duplicated primary studies will be performed and quantified using the CCA and visualised with the graphical representation of overlap for overviews.21 To improve transparency, data extraction with items documenting whether each systematic review performed a GRADE assessment or an equivalent, and their overall certainty ratings will also be reported to strengthen informative and descriptive purposes. Ethics and dissemination Ethical approval is not required as this protocol only describes methodological aspects of the future umbrella review and will use secondary data from previous studies to synthesise data. The findings will be disseminated through publication in a peer-reviewed journal and presentation at scientific meetings. As this study is a protocol for an umbrella review and does not involve human participants or identifiable data, ethics committee approval was not required. Patient and public involvement Patients and the public were not involved in the design, conduct or reporting of this research. Protocol registration This protocol is registered in the Open Science Framework (OSF) under DOI: https://doi.org/10.17605/OSF.IO/GZ3DR Supplementary material